2026-06-08 2026-06-08 , online online, 1,290 € plus tax Claire Blaney https://forum-institut.com/seminar/26122002-beyond-hta-pricing-negotiations-and-managed-entry-agreements-across-europe/referenten/26/26_12/26122002-hta-pricing-models-in-europe-what-is-negotiable_blaney-claire.jpg Beyond HTA: Pricing Negotiations and Managed Entry Agreements across Europe

This seminar gives you a clear, comparative understanding of how innovative pricing and reimbursement agreements are structured and negotiated across the UK, Italy, France, Spain, and Germany.

Topics
  • United Kingdom: Beyound Patient Access Schemes - What is now negotiable?
  • Italy: Payment by results and managed entry agreements
  • France: CEPS agreements
  • Spain: the P&R system, negotiations with the DGCBSSNS, managed entry agreements, and Patient Access Schemes
  • Germany: AMNOG and the prospective cohort model; EU HTA and the 2027 price negotiations


Who should attend
This seminar addresses professionals from the pharmaceutical and biotech industry working in market access, pricing and reimbursement, health economics and commercial strategy. It is equally relevant for those responsible for launch planning of innovative or high-cost therapies who want a comparative European perspective.
Aims and objectives
This seminar gives you a clear, comparative understanding of how innovative pricing and reimbursement agreements are structured and negotiated across the UK, Italy, France, Spain and Germany. You will learn to distinguish financial-based, performance-based, and mixed models and understand the regulatory logic behind each market.

The direct exchange with experienced experts from across Europe allows you to ask the questions that matter for your own projects.
Your benefit

After attending, you will be able to...

  • assess which agreement types fit a given product and market
  • apply insights from concrete cases in high-cost and advanced therapies

HTA Pricing Models in Europe - What is Negotiable?

Beyond HTA: Pricing Negotiations and Managed Entry Agreements across Europe

Benefits
  • Comparison of five European markets in one day
  • Learn from experts and ask your invidivual questions
  • Officially certified to the ISO 9001 and ISO 21001 standards

Webcode 26122002

Book now

JETZT Buchen

Speakers


Everything at a glance

Appointment

01/12/2026

01/12/2026

Period

9:00 am - 5:00 pm seminar
You may dial in 30 minutes in advance

9:00 am - 5:00 pm seminar
You may dial in 30 minutes in advance
Venue

online

online

Fee
Your contact

Dr. Henriette Wolf-Klein
Head of Department

+49 6221 500-680
h.wolf-klein@forum-institut.de

Details

This seminar gives you a clear, comparative understanding of how innovative pricing and reimbursement agreements are structured and negotiated across the UK, Italy, France, Spain, and Germany.

Topics

  • United Kingdom: Beyound Patient Access Schemes - What is now negotiable?
  • Italy: Payment by results and managed entry agreements
  • France: CEPS agreements
  • Spain: the P&R system, negotiations with the DGCBSSNS, managed entry agreements, and Patient Access Schemes
  • Germany: AMNOG and the prospective cohort model; EU HTA and the 2027 price negotiations


Who should attend
This seminar addresses professionals from the pharmaceutical and biotech industry working in market access, pricing and reimbursement, health economics and commercial strategy. It is equally relevant for those responsible for launch planning of innovative or high-cost therapies who want a comparative European perspective.

Aims and objectives

This seminar gives you a clear, comparative understanding of how innovative pricing and reimbursement agreements are structured and negotiated across the UK, Italy, France, Spain and Germany. You will learn to distinguish financial-based, performance-based, and mixed models and understand the regulatory logic behind each market.

The direct exchange with experienced experts from across Europe allows you to ask the questions that matter for your own projects.

Your benefit

After attending, you will be able to...

  • assess which agreement types fit a given product and market
  • apply insights from concrete cases in high-cost and advanced therapies

Detailed programme

9:00 am - 5:00 pm seminar
You may dial in 30 minutes in advance

09:00 Welcome


09:15

Claire Blaney

UK: Beyond Patient Access Schemes (PAS)
  • Threshold Shifts
  • NICE Flexibility
  • What is now negotiable
  • Implications of EUHTA

10:30

Bernd Schollmeier

Italy: Payment by Results - AIFA Registry
  • Payment by results mechanism
  • Success-dependent refunds for non-responders via AIFA registry
  • Managed entry agreements (financial-based, performance-based, mixed models)

11:45 Break


12:00

Alain Estival

France: CEPS Agreements
  • Pricing mechanism in France
  • Negotiation processes (laws/ other guidances/reports)
  • Types of agreements (example of ATMP pricing)

13:15 Lunch break


14:00

Marta Taboada Rodríguez, Teresa Otero

Market Access & Pricing in Spain
  • Spanish P&R system
  • Stakeholders in Spain
  • Negotiation with DGCBSSNS
  • Changes in the evaluation process in Spain: what is already in place and what is expected to come
  • How will EU-HTA fit into the current system?
  • MEAs in Spain
  • Patient Access Schemes

15:30 Break


15:45

Dr. Lydia Frick

Germany: AMNOG and the Prospective Cohort Model
  • Zolgensma, Spinraza, Kymriah, Yescarta - lessons learnt
  • Performance-based agreements on the horizon?
  • Outlook: EU HTA, AMNOG and National Price Negotiations 2027
    • What can be transferred from other countries?
    • What are the implications of the GKV-Beitragssatzstabilisierungsgesetz?

17:00 End of the seminar


Ihr Nutzen

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

Free pre-meeting and technology check

You can attend one of our pre-meetings and explore our Learning Space free of charge. Registration is not required. You can find available dates for a pre-meeting in your customer portal. Click the green ‘Participate’ button in the pre-meeting in the customer portal and you will be redirected to the Learning Space.

The pre-meeting gives you the opportunity to explore our Learning Space and to familiarise yourself with the technology to start off your online training on the right foot. This is a non-binding offer for all our customers and not a prerequisite for participation. If a pre-meeting date does not suit you but you would still like a technology check, please contact us.

This distinguishes our events

of 5 stars of all ratings from 2025

of 5 stars on Trustpilot = good

Recommendations

Market Access & Healthcare Management Fundamentals

Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.

20. - 21.10.2026 in
Details

Market Access of Biosimilars in Europe

Biosimilar uptake in Europe, Aut idem in Germany - these are the challenges for regulatory affairs and market access

28.09.2026 in
Details

Leveraging AI in Evidence Generation and Market Access

Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...

14.10.2026 in
Details

ExpertFORUM Global Regulatory Affairs

This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital tra...

17. - 18.09.2026 in
Details

e-Learning: AMNOG briefly and concisely

e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiation

31.12.2026 in
Details

Go forward

List of abbreviations pharma & healthcare

Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.

Details
Abbreviations, Glossary
Newsletter on trends and findings

Stay up to date - we regularly inform you about new regulatory and professional developments.

Details
Professional know-how free of charge
We guarantee the highest quality

We are now officially certified to ISO 9001 and ISO 21001 standard.

Details
We guarantee the highest quality